Sutro Biopharma, Inc. STRO Hisse Senedi Tahmini
Sutro Biopharma, Inc. için AI destekli fiyat tahmini ve analiz · Güncellenmiş Mar 18, 2026
AI 90 Günlük Tahmin
TUT
7 Gün
30 Gün
90 Gün
Yapay Zeka Güveni: 6% Spearman Korelasyonu
Mart 18, 2026
STRO'in tam fiyat hedefini gör
4.000'den fazla hisse için AI tahminlerini açmak üzere ücretsiz hesap oluşturun
Google ile Ücretsiz Kaydol✓ Ücretsiz hesap · ✓ 30 günlük deneme · ✓ İstediğin zaman iptal et
Fiyat Grafiği
Grafik yükleniyor...
Temel İstatistikler
Piyasa Değeri
$356M
F/K Oranı
-1,0x
P/B Oranı
7,98x
Temettü Verimi
6,48%
HBK
$-2,51
ROE
-43,3%
Net Marj
-855,1%
Gelir
$105M
Cari Oran
5,90x
B/ÖS Oranı
0,20x
Hakkında Sutro Biopharma, Inc.
Sutro Biopharma, Inc. (STRO) Life Sciences sektöründe faaliyet göstermektedir, özellikle Biological Products, (No Diagnostic Substances) endüstrisinde. Şirket yaklaşık 260 kişi istihdam etmektedir.
We do not have any company description for SUTRO BIOPHARMA, INC. at the moment.
Biological Products, (No Diagnostic Substances) Benzer Şirketler
| Şirket | Ticker | AI Sinyali | Piyasa Değeri | F/K |
|---|---|---|---|---|
| Acumen Pharmaceuticals, Inc. | ABOS | ██% | $188M | -1,9x |
| Abpro Holdings, Inc. | ABP | ██% | $310K | -x |
| Abpro Holdings, Inc. | ABPO | ██% | $460K | -x |
| Arcellx, Inc. | ACLX | ██% | $6.65B | -74,1x |
| Alpha Cognition Inc. | ACOG | ██% | $135M | -x |
| Adaptimmune Therapeutics Plc | ADAP | ██% | $77M | -13,2x |
| Adma Biologics, Inc. | ADMA | ██% | $2.17B | 14,8x |
| Adaptive Biotechnologies Corp | ADPT | ██% | $2.23B | -4,6x |
| Adverum Biotechnologies, Inc. | ADVM | ██% | $95M | -1,8x |
| Agenus Inc | AGEN | ██% | $120M | 1047,3x |
| Agentix Corp. | AGTX | ██% | $2M | -x |
| Aim Immunotech Inc. | AIM | ██% | $2M | -0,5x |
| Aim Immunotech Inc. | AIMI | ██% | $1M | -x |
| Alector, Inc. | ALEC | ██% | $284M | -1,2x |
| Aligos Therapeutics, Inc. | ALGS | ██% | $49M | -19,2x |
| Allogene Therapeutics, Inc. | ALLO | ██% | $593M | -1,4x |
| Alvotech | ALVO | ██% | $1.13B | -x |
| Amgen Inc | AMGN | ██% | $190.18B | 24,7x |
| Apogee Therapeutics, Inc. | APGE | ██% | $5.77B | -20,5x |
| Aptose Biosciences Inc. | APTOF | ██% | $4M | -x |
| Argenx Se | ARGX | ██% | $46.03B | -x |
| Armata Pharmaceuticals, Inc. | ARMP | ██% | $378M | -1,0x |
| Artiva Biotherapeutics, Inc. | ARTV | ██% | $165M | -x |
| Leonabio, Inc. | ATHA | ██% | $23M | -0,2x |
| Atara Biotherapeutics, Inc. | ATRA | ██% | $42M | 1,3x |
| Atyr Pharma Inc | ATYR | ██% | $84M | -3,6x |
| Aura Biosciences, Inc. | AURA | ██% | $427M | -4,9x |
| Autolus Therapeutics Plc | AUTL | ██% | $365M | -x |
| Anavex Life Sciences … | AVXL | ██% | $289M | -17,3x |
| Bioatla, Inc. | BCAB | ██% | $11M | -1,1x |
| Biocardia, Inc. | BCDA | ██% | $12M | -0,6x |
| Brainstorm Cell Therapeutics … | BCLI | ██% | $10M | -4,9x |
| Biocryst Pharmaceuticals Inc | BCRX | ██% | $2.35B | 8,9x |
| Black Diamond Therapeutics, … | BDTX | ██% | $133M | 6,0x |
| Beam Therapeutics Inc. | BEAM | ██% | $2.46B | -12,6x |
| Biogen Inc. | BIIB | ██% | $26.98B | 20,9x |
| Biontech Se | BNTX | ██% | $22.47B | -x |
| Cabaletta Bio, Inc. | CABA | ██% | $269M | -1,6x |
| Candel Therapeutics, Inc. | CADL | ██% | $365M | -4,6x |
| C4 Therapeutics, Inc. | CCCC | ██% | $262M | -2,6x |
| Cidara Therapeutics, Inc. | CDTX | ██% | $6.49B | -1,0x |
| Creative Medical Technology … | CELZ | ██% | $7M | -3,4x |
| Cero Therapeutics Holdings, … | CERO | ██% | $650K | -x |
| Cullinan Therapeutics, Inc. | CGEM | ██% | $840M | -4,1x |
| Compugen Ltd | CGEN | ██% | $208M | 2,9x |
| Cg Oncology, Inc. | CGON | ██% | $5.39B | -x |
| Cognition Therapeutics Inc | CGTX | ██% | $79M | -0,5x |
| Coherus Oncology, Inc. | CHRS | ██% | $261M | 1,6x |
| Calidi Biotherapeutics, Inc. | CLDI | ██% | $2M | -0,9x |
| Cellectis S.A. | CLLS | ██% | $340M | -x |
| Compass Therapeutics, Inc. | CMPX | ██% | $968M | -4,8x |
| Mosaic Immunoengineering Inc. | CPMV | ██% | $5M | -x |
| Caribou Biosciences, Inc. | CRBU | ██% | $142M | -1,5x |
| Cardiff Oncology, Inc. | CRDF | ██% | $110M | -4,0x |
| Cardiol Therapeutics Inc. | CRDL | ██% | $156M | -x |
| Curis Inc | CRIS | ██% | $21M | -0,3x |
| Crispr Therapeutics Ag | CRSP | ██% | $4.68B | -12,1x |
| Champions Oncology, Inc. | CSBR | ██% | $82M | 32,9x |
| Cel Sci Corp | CVM | ██% | $29M | -0,9x |
| Dbv Technologies S.A. | DBVT | ██% | $1.14B | -3,3x |
| Dbv Technologies S.A. | DBVTF | ██% | $10K | -x |
| Ginkgo Bioworks Holdings, … | DNA | ██% | $395M | -13,9x |
| Denali Therapeutics Inc. | DNLI | ██% | $3.07B | -8,7x |
| Precision Biosciences Inc | DTIL | ██% | $137M | -2,2x |
| Dyadic International Inc | DYAI | ██% | $31M | -7,3x |
| Editas Medicine, Inc. | EDIT | ██% | $255M | -0,8x |
| Elutia Inc. | ELUT | ██% | $45M | 0,9x |
| Engene Holdings Inc. | ENGN | ██% | $453M | 3,7x |
| Entera Bio Ltd. | ENTX | ██% | $53M | 8,5x |
| Viskase Holdings, Inc. | ENZN | ██% | $4M | -x |
| Estrella Immunopharma, Inc. | ESLA | ██% | $45M | -3,1x |
| Evaxion A/S | EVAX | ██% | $33M | -x |
| Exelixis, Inc. | EXEL | ██% | $11.56B | 14,8x |
| Exozymes Inc. | EXOZ | ██% | $71M | -x |
| Fate Therapeutics Inc | FATE | ██% | $143M | -1,3x |
| 4d Molecular Therapeutics, … | FDMT | ██% | $504M | -3,0x |
| Fennec Pharmaceuticals Inc. | FENC | ██% | $219M | 1758,3x |
| Finch Therapeutics Group, … | FNCH | ██% | $15M | 0,5x |
| Futuretech Ii Acquisition … | FTII | ██% | $52M | -x |
| Futuretech Ii Acquisition … | FTIIU | ██% | $14M | -x |
| Gilead Sciences, Inc. | GILD | ██% | $174.11B | 20,5x |
| Monte Rosa Therapeutics, … | GLUE | ██% | $1.37B | 59,5x |
| Genenta Science S.P.A. | GNTA | ██% | $16M | -x |
| Green Planet Bio … | GPLB | ██% | $340K | -x |
| Greenland Mines Ltd | GRML | ██% | $45M | -x |
| Halozyme Therapeutics, Inc. | HALO | ██% | $7.70B | 24,3x |
| Humacyte, Inc. | HUMA | ██% | $131M | -3,3x |
| Immunitybio, Inc. | IBRX | ██% | $7.22B | -3,6x |
| Inhibikase Therapeutics, Inc. | IKT | ██% | $239M | -1,0x |
| Imagenebio, Inc. | IMA | ██% | $56M | -x |
| Immunocore Holdings Plc | IMCR | ██% | $1.54B | -x |
| Immatics N.V. | IMTX | ██% | $1.34B | -x |
| Immunovant, Inc. | IMVT | ██% | $5.10B | -14,5x |
| In8bio, Inc. | INAB | ██% | $14M | -x |
| Inhibrx Biosciences, Inc. | INBX | ██% | $873M | -6,8x |
| Mink Therapeutics, Inc. | INKT | ██% | $45M | -1,5x |
| Inmune Bio, Inc. | INMB | ██% | $33M | -2,5x |
| Intensity Therapeutics, Inc. | INTS | ██% | $14M | -2,2x |
| Iovance Biotherapeutics, Inc. | IOVA | ██% | $1.42B | -4,5x |
| Century Therapeutics, Inc. | IPSC | ██% | $394M | -0,7x |
| Invivyd, Inc. | IVVD | ██% | $375M | -0,4x |
| Jasper Therapeutics, Inc. | JSPR | ██% | $22M | -3,2x |
| Kalaris Therapeutics, Inc. | KLRS | ██% | $136M | -x |
| Klotho Neurosciences, Inc. | KLTO | ██% | $56M | -x |
| Kodiak Sciences Inc. | KOD | ██% | $2.64B | -2,5x |
| Krystal Biotech, Inc. | KRYS | ██% | $7.56B | 36,9x |
| Kymera Therapeutics, Inc. | KYMR | ██% | $6.91B | -17,8x |
| Kyverna Therapeutics, Inc. | KYTX | ██% | $530M | -x |
| Ladrx Corp | LADX | ██% | $20K | -x |
| Lineage Cell Therapeutics, … | LCTX | ██% | $387M | -4,7x |
| Lenz Therapeutics, Inc. | LENZ | ██% | $293M | -6,7x |
| Liminatus Pharma, Inc. | LIMN | ██% | $7M | -x |
| Leonabio, Inc. | LONA | ██% | $94M | -x |
| Lexeo Therapeutics, Inc. | LXEO | ██% | $414M | -0,4x |
| Maze Therapeutics, Inc. | MAZE | ██% | $1.43B | -x |
| Mesoblast Ltd | MESO | ██% | $2.07B | -x |
| Meiragtx Holdings Plc | MGTX | ██% | $737M | -3,4x |
| Metagenomi Therapeutics, Inc. | MGX | ██% | $50M | -x |
| Molecular Partners Ag | MOLN | ██% | $162M | -x |
| Moderna, Inc. | MRNA | ██% | $19.71B | -3,2x |
| Neurocrine Biosciences Inc | NBIX | ██% | $13.27B | 27,7x |
| Nkgen Biotech, Inc. | NKGN | ██% | $2M | -0,1x |
| Neumora Therapeutics, Inc. | NMRA | ██% | $364M | -3,9x |
| Novavax Inc | NVAX | ██% | $1.30B | 3,0x |
| Ocugen, Inc. | OCGN | ██% | $559M | -4,3x |
| Outlook Therapeutics, Inc. | OTLK | ██% | $22M | -0,2x |
| Palisade Bio, Inc. | PALI | ██% | $291M | -0,2x |
| Passage Bio, Inc. | PASG | ██% | $22M | -0,6x |
| Vaxcyte, Inc. | PCVX | ██% | $7.62B | -20,4x |
| Biomx Inc. | PHGE | ██% | $8M | 1,5x |
| Pluri Inc. | PLUR | ██% | $34M | -1,4x |
| Protalix Biotherapeutics, Inc. | PLX | ██% | $173M | 41,2x |
| Pharmacyte Biotech, Inc. | PMCB | ██% | $8M | 0,3x |
| Prime Medicine, Inc. | PRME | ██% | $617M | -1,5x |
| Prokidney Corp. | PROK | ██% | $526M | -x |
| Qiagen N.V. | QGEN | ██% | $9.11B | -x |
| Quince Therapeutics, Inc. | QNCX | ██% | $5M | -1,7x |
| Qrons Inc. | QRON | ██% | $150K | -x |
| Replimune Group, Inc. | REPL | ██% | $602M | -3,8x |
| Repligen Corp | RGEN | ██% | $6.61B | 135,2x |
| Regenxbio Inc. | RGNX | ██% | $418M | -1,8x |
| Relay Therapeutics, Inc. | RLAY | ██% | $1.84B | -2,0x |
| Revolution Medicines, Inc. | RVMD | ██% | $19.08B | -11,1x |
| Recursion Pharmaceuticals, Inc. | RXRX | ██% | $1.58B | -4,7x |
| Sab Biotherapeutics, Inc. | SABS | ██% | $273M | 20,6x |
| Sana Biotechnology, Inc. | SANA | ██% | $740M | -2,1x |
| Scilex Holding Co | SCLX | ██% | $47M | -0,4x |
| Scinai Immunotherapeutics Ltd. | SCNI | ██% | $2M | -287,8x |
| Sangamo Therapeutics, Inc | SGMO | ██% | $82M | -1,6x |
| Solid Biosciences Inc. | SLDB | ██% | $715M | -0,9x |
| Silexion Therapeutics Corp | SLXN | ██% | $4M | -x |
| Senti Biosciences, Inc. | SNTI | ██% | $24M | -1,1x |
| Scholar Rock Holding … | SRRK | ██% | $5.22B | -18,5x |
| Surrozen, Inc./De | SRZN | ██% | $343M | -0,5x |
| Sutro Biopharma, Inc. | STRO | ██% | $356M | -1,0x |
| Protara Therapeutics, Inc. | TARA | ██% | $278M | -2,1x |
| Tarsus Pharmaceuticals, Inc. | TARS | ██% | $2.87B | -12,4x |
| Tc Biopharm (Holdings) … | TCBPY | ██% | $10K | -x |
| Tscan Therapeutics, Inc. | TCRX | ██% | $57M | -4,6x |
| Bio-Techne Corp | TECH | ██% | $8.20B | 101,1x |
| Tectonic Therapeutic, Inc. | TECX | ██% | $587M | -8,9x |
| Instil Bio, Inc. | TIL | ██% | $56M | -1,1x |
| Tenaya Therapeutics, Inc. | TNYA | ██% | $159M | -2,5x |
| Tourmaline Bio, Inc. | TRML | ██% | $1.23B | -3,5x |
| Taysha Gene Therapies, … | TSHA | ██% | $1.26B | -3,0x |
| Titan Pharmaceuticals Inc | TTNP | ██% | $6M | -0,5x |
| Tevogen Bio Holdings … | TVGN | ██% | $17M | -x |
| Twist Bioscience Corp | TWST | ██% | $2.85B | -12,6x |
| Voyager Acquisition Corp./Cayman … | VACH | ██% | $372M | 41,3x |
| Voyager Acquisition Corp./Cayman … | VACHU | ██% | $68M | 6,7x |
| Valneva Se | VALN | ██% | $548M | -x |
| Vericel Corp | VCEL | ██% | $1.61B | 97,7x |
| Vir Biotechnology, Inc. | VIR | ██% | $1.47B | -2,0x |
| Vivosim Labs, Inc. | VIVS | ██% | $4M | -x |
| Vor Biopharma Inc. | VOR | ██% | $738M | -0,6x |
| Vaxart, Inc. | VXRT | ██% | $146M | 8,9x |
| Voyager Therapeutics, Inc. | VYGR | ██% | $238M | 570,6x |
| Windtree Therapeutics Inc … | WINT | ██% | $320K | -0,4x |
| X4 Pharmaceuticals, Inc | XFOR | ██% | $375M | 6,4x |
| Zeo Scientifix, Inc. | ZEOX | ██% | $17M | -x |
| Zivo Bioscience, Inc. | ZIVO | ██% | $26M | -31,3x |
| Zura Bio Ltd | ZURA | ██% | $565M | -x |
SSS
-
Sutro Biopharma, Inc. satın alınacak iyi bir hisse mi?
AI'mız Sutro Biopharma, Inc.'i günlük olarak analiz eder. En son öneri için yukarıdaki sinyali kontrol edin. Yatırım yapmadan önce her zaman kendi araştırmanızı yapın.
-
Sutro Biopharma, Inc. tahminleri ne kadar doğru?
AI'mız bu hisse için 6% Spearman korelasyonu elde eder, günlük analiz edilen 4.000'den fazla hissede ortalama %67+ doğruluk oranıyla.
-
Tahminler ne sıklıkla güncellenir?
Sutro Biopharma, Inc. tahminleri en son piyasa verileri ve AI modelleri kullanılarak günlük olarak güncellenir.
Daha akıllı yatırım yapmaya hazır mısınız?
AI destekli hisse tahminlerini kullanan binlerce yatırımcıya katılın
Ücretsiz Kaydolun✓ Ücretsiz hesap · ✓ 4.000+ hisse · ✓ Günlük güncellemeler
Sutro Biopharma, Inc. için daha derin bir analiz mi arıyorsunuz?
Intratio'da tam kurumsal düzey analizi görüntüle →AI tahminleri tarihsel kalıplara dayanır ve yatırım kararlarının tek dayanağı olmamalıdır. Geçmiş performans gelecekteki sonuçları garanti etmez. Her zaman kendi araştırmanızı yapın.